Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Shan

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Journal of Ovarian Research|December 29, 2022
The effects of neutral argon plasma versus electrocoagulation on tissue in advanced-stage ovarian cancer: a case seriesGatske M Nieuwenhuyzen-de Boer, Nick J van de Berg, Xu Shan Gao, et al.
Future Oncology (London, England)|March 27, 2018
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTECXu Shan Sun, Cécile Michel, Emmanuel Babin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 18, 2022
A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking StudiesZhang Linlin, Lai Ciai, Su Yanhong, et al.
Clinical Lung Cancer|March 5, 2010
Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancerPierre-Jean Souquet, Maciej Krzakowski, Rodrig Ramlau, et al.
F1000Research|December 4, 2020
Coping strategies of students for anxiety during the COVID-19 pandemic in China: a cross-sectional studyMohammad Nurunnabi, Syed Far Abid Hossain Hossain, Karuthan Chinna, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2015
Discovery and characterization of a potent and selective EP4 receptor antagonistMatthew A Schiffler, Srinivasan Chandrasekhar, Matthew J Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2015
Discovery of substituted-2,4-dimethyl-(naphthalene-4-carbonyl)amino-benzoic acid as potent and selective EP4 antagonistsMaria-Jesus Blanco, Tatiana Vetman, Srinivasan Chandrasekhar, et al.
Journal of Biomedical Nanotechnology|February 22, 2018
Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular CarcinomaHeng Zhang, Yu Jiang, XiaoLing Ni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 10, 2013
Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese populationZi-Yi Jin, Ming Wu, Ren-Qiang Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2016
Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profileMaria-Jesus Blanco, Tatiana Vetman, Srinivasan Chandrasekhar, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Journal of Ovarian Research|December 29, 2022
The effects of neutral argon plasma versus electrocoagulation on tissue in advanced-stage ovarian cancer: a case seriesGatske M Nieuwenhuyzen-de Boer, Nick J van de Berg, Xu Shan Gao, et al.
Future Oncology (London, England)|March 27, 2018
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTECXu Shan Sun, Cécile Michel, Emmanuel Babin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 18, 2022
A Multi-Target and Multi-Channel Mechanism of Action for Jiawei Yinhuo Tang in the Treatment of Social Communication Disorders in Autism: Network Pharmacology and Molecular Docking StudiesZhang Linlin, Lai Ciai, Su Yanhong, et al.
Clinical Lung Cancer|March 5, 2010
Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancerPierre-Jean Souquet, Maciej Krzakowski, Rodrig Ramlau, et al.
F1000Research|December 4, 2020
Coping strategies of students for anxiety during the COVID-19 pandemic in China: a cross-sectional studyMohammad Nurunnabi, Syed Far Abid Hossain Hossain, Karuthan Chinna, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2015
Discovery and characterization of a potent and selective EP4 receptor antagonistMatthew A Schiffler, Srinivasan Chandrasekhar, Matthew J Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2015
Discovery of substituted-2,4-dimethyl-(naphthalene-4-carbonyl)amino-benzoic acid as potent and selective EP4 antagonistsMaria-Jesus Blanco, Tatiana Vetman, Srinivasan Chandrasekhar, et al.
Journal of Biomedical Nanotechnology|February 22, 2018
Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular CarcinomaHeng Zhang, Yu Jiang, XiaoLing Ni, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 10, 2013
Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese populationZi-Yi Jin, Ming Wu, Ren-Qiang Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2016
Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profileMaria-Jesus Blanco, Tatiana Vetman, Srinivasan Chandrasekhar, et al.
Pageof 12